OGC
MRNA icon

Oak Grove Capital’s Moderna MRNA Stock Holding History

Oak Grove Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,790
Closed -$212K – 61
2022
Q3 		$212K Sell
1,790
-567
-24% -$86K 0.07% 54
2022
Q2 		$337K Sell
2,357
-3,333
-59% -$476K 0.11% 51
2022
Q1 		$980K Buy
5,690
+100
+2% +$16.8K 0.2% 46
2021
Q4 		$1.42M Buy
5,590
+950
+20% +$278K 0.25% 54
2021
Q3 		$1.79M Buy
4,640
+440
+10% +$162K 0.39% 48
2021
Q2 		$987K Buy
4,200
+2,600
+163% +$465K 0.22% 58
2021
Q1 		$210K Buy
+1,600
New +$232K 0.06% 82

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oak Grove Capital's MRNA Position: Q4 2022 in Review

Oak Grove Capital sold out of Moderna (MRNA) in Q4 2022, closing a stake of 1,790 shares — an estimated $212K sold.

Oak Grove Capital first reported a position in MRNA in Q1 2021 and held it in 7 quarters. The position peaked at $1.79M in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Oak Grove Capital reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Oak Grove Capital sold 1,790 Moderna shares in Q4 2022, an estimated $212K.
  • Oak Grove Capital first reported a position in Moderna in Q1 2021 and held it in 7 quarters.
  • Oak Grove Capital's Moderna position peaked at $1.79M in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Oak Grove Capital's 13F filing for Q4 2022, filed 8 Feb 2023.